Managers / Q4 2020 · view latest →
HC Advisors, LLC
CIK 0001803295 · 750 HAMMOND DRIVE, BDG 1, SUITE 200, SANDY SPRINGS, GA, 30328 · 4047054593
Reported Value
$146M
Q4 2020
Positions
87
Filings on Record
26
2019–present window
Filed
Feb 8, 2021
original filing
Summary
Hc Advisors, LLC reported $146M in U.S.-listed holdings across 87 positions for Q4 2020.
Its largest position, Vanguard Index Fds, represents 16.0% of the portfolio.
Compared with Q3 2020, the fund opened 15 new positions and exited 4.
Portfolio Metrics
Turnover
+2.1%
vs prior filed quarter
Top-10 Concentration
+63.2%
share of reported value
Largest Position
+16.0%
Vanguard Index Fds
New / Exited
15 / 4
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- ETP · 84.3% · $123M
- Common Stock · 11.9% · $17M
- Closed-End Fund · 2.0% · $3M
- Other · 1.5% · $2M
- ADR · 0.2% · $332,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPDR S&P 500 ETF TR | NEW | +3.5K | 3.5K | +$1M | $1M |
| TGTXTG THERAPEUTICS INC | NEW | +12.8K | 12.8K | +$668,000 | $668,000 |
| CYTKCYTOKINETICS INC | NEW | +29.7K | 29.7K | +$617,000 | $617,000 |
| GOOGLALPHABET INC | NEW | +240 | 240 | +$421,000 | $421,000 |
| UNUM THERAPEUTICS INC | NEW | +31.4K | 31.4K | +$353,000 | $353,000 |
| APLSUSDAPELLIS PHARMACEUTICALS INC | NEW | +5.7K | 5.7K | +$327,000 | $327,000 |
| CSCOCISCO SYS INC | NEW | +6.9K | 6.9K | +$307,000 | $307,000 |
| LCA2GUSDGOLDEN NUGGET ONLINE GAMIN | NEW | +13.1K | 13.1K | +$259,000 | $259,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
39 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SCHWAB STRATEGIC TR | INTRM TRM TRES · EMRG MKTEQ ETF · US TIPS ETF · US DIVIDEND EQ · US LCAP GR ETF · US MID-CAP ETF · US SML CAP ETF | 29.64% | $43M | 797.4K |
| 2 | VANGUARD INDEX FDS | TOTAL STK MKT · S&P 500 ETF SHS | 16.58% | $24M | 122.6K |
| 3 | FIRST TR MORNINGSTAR DIV LEA | SHS | 6.70% | $10M | 331.2K |
| 4 | iShares Treasury 7-10 Yr Bond | BARCLAYS 7 10 YR | 4.65% | $7M | 56.7K |
| 5 | iShares US Tech ETF | U.S. TECH ETF | 4.22% | $6M | 72.6K |
| 6 | IYFiShares US Financials ETFhistory → | U.S. FINLS ETF | 3.50% | $5M | 76.8K |
| 7 | Wisdom Tree Small Cap Div Fund ETF | COM | 3.02% | $4M | 165.9K |
| 8 | iShares US Healthcare ETF | US HLTHCARE ETF | 2.14% | $3M | 12.7K |
| 9 | Vanguard Russell | VNG RUS1000VAL · VNG RUS1000GRW | 2.13% | $3M | 19.7K |
| 10 | iShares Global Comm Svcs | GBL COMM SVC ETF | 2.00% | $3M | 39.5K |
| 11 | AAPLAPPLE INChistory → | COM | 1.92% | $3M | 21.1K |
| 12 | VDCVanguard Consumer Stapleshistory → | CONSUM STP ETF | 1.55% | $2M | 13.0K |
| 13 | Schwab US Agg Bond ETF | US AGGREGATE B | 1.17% | $2M | 30.5K |
| 14 | Vanguard Intl Eqty Index | ALLWRLD EX US | 1.11% | $2M | 27.9K |
| 15 | Ishares Russell | RUSSELL 3000 ETF · RUS 1000 GRW ETF | 1.02% | $1M | 6.5K |
| 16 | VANGUARD SCOTTSDALE FDS | VNG RUS2000GRW · INT-TERM CORP · VNG RUS3000IDX | 0.97% | $1M | 9.9K |
| 17 | SPDR S&P 500 ETF TR | TR UNIT | 0.89% | $1M | 3.5K |
| 18 | Schwab Int'l Equity ETF | INTL EQTY ETF | 0.78% | $1M | 31.6K |
| 19 | SPROTT PHYSICAL GOLD TRUST | UNIT | 0.68% | $993,000 | 65.8K |
| 20 | RETAEURREATA PHARMACEUTICALS INC | CL A | 0.63% | $921,000 | 7.5K |
| 21 | AMZNAMAZON COM INC | COM | 0.61% | $899,000 | 276 |
| 22 | Vanguard Small Cap Valu | SM CP VAL ETF | 0.58% | $855,000 | 6.0K |
| 23 | ALXOALX ONCOLOGY HLDGS INC | COM | 0.58% | $845,000 | 9.8K |
| 24 | SPROTT PHYSICAL SILVER TR | TR UNIT | 0.57% | $829,000 | 88.7K |
| 25 | HDHome Depot Inc | COM | 0.51% | $748,000 | 2.8K |
| 26 | SRPTSAREPTA THERAPEUTICS INC | COM | 0.50% | $730,000 | 4.3K |
| 27 | PAASPAN AMERICAN SILVER CORP | COM | 0.47% | $681,000 | 19.7K |
| 28 | NRGXEURPIMCO ENRGY TACTICAL CR OPP | COM SHS BEN INT | 0.46% | $678,000 | 83.9K |
| 29 | TGTXTG THERAPEUTICS INC | COM | 0.46% | $668,000 | 12.8K |
| 30 | Vanguard MSCI EAFE Etf | FTSE DEV MKT ETF | 0.45% | $657,000 | 13.9K |
| 31 | CRISPR THERAPEUTICS AG | NAMEN AKT | 0.44% | $646,000 | 4.2K |
| 32 | CYTKCYTOKINETICS INC | COM NEW | 0.42% | $617,000 | 29.7K |
| 33 | NMI1EURKIRKLAND LAKE GOLD LTD | COM | 0.33% | $483,000 | 11.7K |
| 34 | KOCoca Cola Company | COM | 0.32% | $466,000 | 8.5K |
| 35 | Vanguard Small Cap Grwth | SML CP GRW ETF | 0.31% | $455,000 | 1.7K |
| 36 | MSFTMicrosoft Corp | COM | 0.31% | $447,000 | 2.0K |
| 37 | AEMAGNICO EAGLE MINES F | COM | 0.30% | $446,000 | 6.3K |
| 38 | GOOGLALPHABET INC | CAP STK CL A | 0.29% | $421,000 | 240 |
| 39 | ASCENDIS PHARMA A S | SPONSORED ADR | 0.28% | $416,000 | 2.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $149M | 60 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $145M | 60 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $142M | 61 | Nov 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $142M | 60 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $134M | 62 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $125M | 59 | Feb 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $122M | 53 | Nov 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $108M | 50 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $210M | 91 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $179M | 87 | Jan 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $168M | 83 | Nov 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $172M | 83 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $162M | 81 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $146M | 84 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $145M | 85 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $140M | 80 | Aug 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $158M | 83 | May 6, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $163M | 86 | Feb 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $152M | 81 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $163M | 82 | Aug 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $155M | 89 | May 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $146M | 87 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $124M | 76 | Nov 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $121M | 79 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $23M | 29 | May 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $97M | 44 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.